Heikki Lanckriet Buys 46,500 Shares of 4basebio PLC (LON:4BB) Stock

4basebio PLC (LON:4BB) insider Heikki Lanckriet purchased 46,500 shares of the stock in a transaction dated Friday, November 15th. The shares were purchased at an average cost of GBX 1,325 ($16.80) per share, for a total transaction of £616,125 ($780,992.52).

4basebio Stock Performance

4basebio stock traded down GBX 40 ($0.51) during mid-day trading on Tuesday, reaching GBX 1,260 ($15.97). 183 shares of the stock traded hands, compared to its average volume of 4,601. The stock has a market capitalization of £161.41 million, a PE ratio of -1,615.38 and a beta of 1.09. The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52. The business’s 50-day moving average is GBX 1,346.45 and its 200-day moving average is GBX 1,410.28. 4basebio PLC has a 12-month low of GBX 500 ($6.34) and a 12-month high of GBX 1,820 ($23.07).

4basebio Company Profile

4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines.